Parkinsonism and Related Disorders

Background: Patient telephone calls are a major form of unreimbursed healthcare utilization in Parkinson’s disease (PD), yet little is known about potential risk factors for frequent calling behavior. Methods: Prospective cohort study of 175 non-demented outpatients with PD. Our primary outcome measure was the frequency of patient telephone calls over a three-month period relative to baseline demographics, State-Trait Anxiety Index (STAI) and Beck Anxiety Inventory (BAI) scores, Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores, and medication use. Based on the median call rate (1 call/3 months), subjects were dichotomized into frequent ( 2 calls) and infrequent ( 1 call) caller groups. Results: A total of 297 calls were received, of which 264 (89%) were from the frequent caller group (n 1⁄4 63 subjects), and only 33 (11%) were from the infrequent caller group (n 1⁄4 112 subjects). Compared with calls from infrequent callers, those from frequent callers more commonly related to somatic symptoms of PD (46.8% vs. 19.4%, p 1⁄4 0.007). In multivariate logistic regression analysis, independent predictors of frequent calling were: anxiety (STAI 55; adjusted OR 1⁄4 2.62, p 1⁄4 0.02), sleep disorders (adjusted OR 1⁄4 2.36, p 1⁄4 0.02), dyskinesias (adjusted OR 1⁄4 3.07, p 1⁄4 0.03), and dopamine agonist use (adjusted OR 1⁄4 2.27, p 1⁄4 0.03). Baseline demographics, UPDRS motor scores, and levodopa use were similar in both groups. Conclusions: Frequent patient telephone calls in PD are independently associated with anxiety, sleep disorders, dyskinesias, and dopamine agonist use, with a minority of patients accounting for the majority of calls. Aggressive treatment of these non-motor symptoms and motor complications might potentially reduce the burden of patient telephone calls in PD. 2010 Elsevier Ltd. All rights reserved.

[1]  Ronald Ranvaud,et al.  The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil , 2008, Movement disorders : official journal of the Movement Disorder Society.

[2]  Z. Slezáková,et al.  Quality of life in patients with Parkinsons disease , 2013 .

[3]  M Emre,et al.  Attentional deficits affect activities of daily living in dementia-associated with Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  K. Gwet Computing inter-rater reliability and its variance in the presence of high agreement. , 2008, The British journal of mathematical and statistical psychology.

[5]  R. Barker,et al.  Tracking Parkinson’s: Study Design and Baseline Patient Data , 2015, Journal of Parkinson's disease.

[6]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[7]  M. Craske,et al.  Anxiety in primary care , 2006, Current psychiatry reports.

[8]  Rui Imamura,et al.  Olfaction in Neurologic and Neurodegenerative Diseases: A Literature Review , 2014, International Archives of Otorhinolaryngology.

[9]  R. Mayeux,et al.  The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism , 2003, Neurology.

[10]  R. Postuma,et al.  Risk Factor Profile in Parkinson's Disease Subtype with REM Sleep Behavior Disorder. , 2016, Journal of Parkinson's disease.

[11]  Anette Schrag,et al.  Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations , 2011, Movement disorders : official journal of the Movement Disorder Society.

[12]  Paul E. Milligan,et al.  Patient and physician satisfaction with a telephone-based anticoagulation service , 2001, Journal of General Internal Medicine.

[13]  R. Doty,et al.  Development of the 12‐Item Cross‐Cultural Smell Identification Test(CC‐SIT) , 1996, The Laryngoscope.

[14]  Oren Cohen,et al.  Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. , 2003, Archives of neurology.

[15]  M. Matsuura,et al.  Do patients with rapid eye movement sleep behavior disorder have a disease-specific personality? , 2012, Parkinsonism & related disorders.

[16]  Ulf Persson,et al.  Resource use and costs in a Swedish cohort of patients with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[17]  R. Elble,et al.  Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[18]  M. Kringelbach,et al.  A systematic review of impulse control disorders in Parkinson's disease. , 2013, Journal of Parkinson's disease.

[19]  A. Stiggelbout,et al.  A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  R. Doty,et al.  A study of the test-retest reliability of ten olfactory tests. , 1995, Chemical senses.

[21]  Knut Engedal,et al.  The Spielberger State‐Trait Anxiety Inventory (STAI): the state scale in detecting mental disorders in geriatric patients , 2005, International journal of geriatric psychiatry.

[22]  O. Tucha,et al.  Neuropsychological and Emotional Correlates of Personality Traits in Parkinson’s Disease , 2013, Behavioural neurology.

[23]  S. Landau,et al.  Cognition, coping, and outcome in Parkinson's disease , 2012, International Psychogeriatrics.

[24]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[25]  A J Lees,et al.  Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  R. Barker,et al.  Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients , 2016, Acta neurologica Scandinavica.

[27]  H. Shill,et al.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease , 2014, Neurology.

[28]  T. Babić,et al.  Is quality of life in non‐demented Parkinson’s disease patients related to cognitive performance? A clinic‐based cross‐sectional study , 2008, European journal of neurology.

[29]  Gerd Kobal,et al.  Screening of Olfactory Function with a Four-Minute Odor Identification Test: Reliability, Normative Data, and Investigations in Patients with Olfactory Loss , 2001, The Annals of otology, rhinology, and laryngology.

[30]  杨文秀,et al.  此处“personality”译法探析 , 2000 .

[31]  R. Tsuyuki Periodic telephone counseling for polypharmacy improved compliance and reduced mortality. , 2007, ACP journal club.

[32]  Jean-François Gagnon,et al.  New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.

[33]  K. Dujardin,et al.  Anxiety rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[34]  Ludovica Griffanti,et al.  Aberrant functional connectivity within the basal ganglia of patients with Parkinson's disease , 2015, NeuroImage: Clinical.

[35]  Richard L Doty,et al.  The olfactory system and its disorders. , 2009, Seminars in neurology.

[36]  Daniel Weintraub,et al.  Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease , 2007, Nature Clinical Practice Neurology.

[37]  M. Stacy,et al.  Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease , 2003, Neurology.

[38]  M. Nirenberg Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery. , 2010, Brain : a journal of neurology.

[39]  C. Semenza,et al.  Cognitive and Personality Features in Parkinson Disease: 2 Sides of the Same Coin? , 2009, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[40]  S. Friis,et al.  Clinical Features in a Danish Population-Based Cohort of Probable Multiple System Atrophy Patients , 2016, Neuroepidemiology.

[41]  E. Tolosa,et al.  The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.

[42]  D. Huse,et al.  Burden of illness in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[43]  Yoav Ben-Shlomo,et al.  REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[45]  H. Vankova Mini Mental State , 2010 .

[46]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[47]  I. McKeith,et al.  Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System , 2002, Dementia and Geriatric Cognitive Disorders.

[48]  M. T. Pellecchia,et al.  Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. , 2016, Parkinsonism & related disorders.

[49]  B. Linn,et al.  Effectiveness of an Ambulatory Care Telephone Service in Reducing Drop-In Visits and Improving Satisfaction With Care , 1982, Medical care.

[50]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[51]  David R Williams,et al.  The use of a color coded probability scale to interpret smell tests in suspected parkinsonism , 2009, Movement disorders : official journal of the Movement Disorder Society.

[52]  R. Monastero,et al.  The neuropsychiatric profile of Parkinson’s disease subjects with and without mild cognitive impairment , 2013, Journal of Neural Transmission.

[53]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[54]  E. Tolosa,et al.  Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD , 2015, Neurology.

[55]  R B Wallace,et al.  The health burdens of Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[56]  P. Schofield,et al.  An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease , 2012, BMC Neurology.

[57]  A. Lees,et al.  The pre-morbid personality of patients with Parkinson's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[58]  Lindy D Wood Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinson’s Disease , 2010, Drugs & aging.

[59]  M. Nirenberg,et al.  Dopamine agonist withdrawal syndrome in Parkinson disease. , 2010, Archives of neurology.

[60]  U. Bonuccelli,et al.  Personality traits in patients with Parkinson’s disease: assessment and clinical implications , 2012, Journal of Neurology.

[61]  C. Holly Structured telephone support or telemonitoring programmes for patients with chronic heart failure , 2011 .

[62]  R. Marconi,et al.  Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[63]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[64]  N. Pedersen,et al.  Personality traits and the risk for Parkinson disease: a prospective study , 2015, European Journal of Epidemiology.

[65]  R. Holloway,et al.  Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries , 2006, Movement disorders : official journal of the Movement Disorder Society.

[66]  R. Barker,et al.  Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[67]  P. Moberg,et al.  Odor identification in Huntington's disease patients and asymptomatic gene carriers. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[68]  J. McQuaid,et al.  The Montreal Cognitive Assessment , 2015, Journal of the International Association of Providers of AIDS Care.

[69]  Comorbid disorders and hospitalisation in Parkinson’s disease: a prospective study , 2004, Neurological Sciences.

[70]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .

[71]  T. Hummel,et al.  High test-retest reliability of the extended version of the "Sniffin' Sticks" test. , 2009, Chemical senses.

[72]  M. T. Pellecchia,et al.  Quitting smoking: an early non-motor feature of Parkinson's disease? , 2015, Parkinsonism & related disorders.

[73]  Markus Wolfensberger,et al.  Sniffin'Sticks: a New Olfactory Test Battery , 2000, Acta oto-laryngologica.

[74]  Regina Katzenschlager,et al.  Olfaction and Parkinson's syndromes: its role in differential diagnosis , 2004, Current opinion in neurology.

[75]  R. Petersen,et al.  Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia , 1998, Neurology.

[76]  Luc Defebvre,et al.  Cognitive disorders in Parkinson's disease: Confirmation of a spectrum of severity. , 2015, Parkinsonism & related disorders.

[77]  R. Doty,et al.  Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.

[78]  R. Postuma,et al.  Parkinson risk in idiopathic REM sleep behavior disorder , 2015, Neurology.

[79]  Shuohua Chen,et al.  Risk factors for probable REM sleep behavior disorder , 2016, Neurology.

[80]  Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial , 2008, Journal of Neurology, Neurosurgery & Psychiatry.

[81]  O. John,et al.  Ten facet scales for the Big Five Inventory: Convergence with NEO PI-R facets, self-peer agreement, and discriminant validity , 2009 .

[82]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[83]  C. R. Cloninger,et al.  A psychobiological model of temperament and character. , 1993, Archives of general psychiatry.

[84]  D. Burn,et al.  Hyposmia in progressive supranuclear palsy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[85]  R. Postuma,et al.  Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. , 2009, Brain : a journal of neurology.

[86]  R. O'Hara,et al.  The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. , 2009, Psychology and aging.

[87]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[88]  D. Weintraub,et al.  Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo‐controlled study , 2015, Movement disorders : official journal of the Movement Disorder Society.

[89]  K Whetten-Goldstein,et al.  The Burden of Parkinson's Disease on Society, Family, and the Individual , 1997, Journal of the American Geriatrics Society.

[90]  M. Kuijf,et al.  Prevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysis , 2016, Movement disorders : official journal of the Movement Disorder Society.

[91]  M. J. Nirenberg,et al.  Carbidopa/levodopa pharmacy errors in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[92]  D. Mezzapesa,et al.  Parkinsonian syndromes , 2008, Neurological Sciences.

[93]  A. Lang,et al.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.

[94]  A. Feinstein,et al.  High agreement but low kappa: I. The problems of two paradoxes. , 1990, Journal of clinical epidemiology.

[95]  Andrew J. Lees,et al.  Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.

[96]  K. Sigvardt,et al.  Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study , 2015, Applied neuropsychology. Adult.

[97]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[98]  Daniel Weintraub,et al.  Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. , 2009, Parkinsonism & related disorders.

[99]  D. Segal,et al.  Late life anxiety is associated with decreased memory and executive functioning in community dwelling older adults. , 2013, Journal of anxiety disorders.

[100]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[101]  G. Byrne,et al.  Interventions for generalized anxiety disorder in older adults: systematic review and meta-analysis. , 2012, Journal of anxiety disorders.

[102]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[103]  R. Fitzpatrick,et al.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. , 1997, Age and ageing.

[104]  A. Lees,et al.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.

[105]  S. Kinkade An exercise and telephone follow-up programme reduced emergency readmissions and improved quality of life in older people , 2009, Evidence-based medicine.

[106]  J. Jankovic,et al.  The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. , 2000, Archives of neurology.

[107]  N. Pachana,et al.  Disease-specific anxiety symptomatology in Parkinson's disease , 2016, International Psychogeriatrics.

[108]  A. Pisani,et al.  The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life , 2012, Journal of Neurology.

[109]  T. Robbins,et al.  Characterizing mild cognitive impairment in incident Parkinson disease , 2014, Neurology.

[110]  Katherine J. Jones,et al.  Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[111]  R. Barker,et al.  Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease , 2016, Parkinsonism & related disorders.

[112]  T. Robbins,et al.  Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .

[113]  P. Curtis,et al.  Characteristics and perceptions of after-hours callers. , 1985, Family practice.

[114]  M. Mark,et al.  Psychogenic parkinsonism: clinical spectrum and diagnosis. , 2015, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[115]  Miguel A Hernán,et al.  A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease , 2002, Annals of neurology.

[116]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[117]  C. Tanner,et al.  Association of olfactory dysfunction with risk for future Parkinson's disease , 2008, Annals of neurology.

[118]  Thomas Hummel,et al.  Olfactory dysfunction in cerebellar ataxia and multiple system atrophy , 2003, Journal of Neurology.

[119]  G. Naglie,et al.  Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment , 2012, Dementia and Geriatric Cognitive Disorders Extra.

[120]  R. Barker,et al.  Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[121]  Angelo Antonini,et al.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[122]  W. Weiner,et al.  Comorbidity of the nonmotor symptoms of Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[123]  Keith Wesnes,et al.  The cognitive drug research computerized assessment system in the evaluation of early dementia‐is speed of the essence? , 1995 .

[124]  G. Wenning,et al.  Tremor in Multiple System Atrophy – a review , 2013, Tremor and other hyperkinetic movements.

[125]  I. T. Draper THE ASSESSMENT OF APHASIA AND RELATED DISORDERS , 1973 .

[126]  Antonio Cerasa,et al.  Neurofunctional correlates of attention rehabilitation in Parkinson’s disease: an explorative study , 2014, Neurological Sciences.

[127]  A. Berardelli,et al.  Rest tremor in idiopathic adult‐onset dystonia , 2016, European journal of neurology.

[128]  U. Emre,et al.  Olfactory dysfunction in multiple sclerosis. , 2018, Multiple sclerosis and related disorders.

[129]  Jacques Montplaisir,et al.  Polysomnographic features of REM sleep behavior disorder , 1992, Neurology.

[130]  S. Bowden,et al.  Accuracy of the Wechsler Test of Adult Reading (WTAR) and National Adult Reading Test (NART) when estimating IQ in a healthy Australian sample , 2007 .

[131]  P. Borghammer,et al.  The parkinsonian personality and concomitant depression. , 2011, The Journal of neuropsychiatry and clinical neurosciences.

[132]  A. Mackay-Sim,et al.  Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects , 2007, European Archives of Oto-Rhino-Laryngology.

[133]  M. Appelbaum,et al.  Psychometric methods. , 1989, Annual review of psychology.

[134]  M. Stern,et al.  A controlled investigation of current and premorbid personality: Characteristics of Parkinson's disease patients , 1995, Movement disorders : official journal of the Movement Disorder Society.

[135]  F. Alarcón,et al.  Post-stroke movement disorders: report of 56 patients , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[136]  C. Waters,et al.  Compulsive eating and weight gain related to dopamine agonist use , 2006, Movement disorders : official journal of the Movement Disorder Society.

[137]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.

[138]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[139]  J. Jankovic,et al.  How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale , 2013, Movement disorders : official journal of the Movement Disorder Society.

[140]  R. Doty Studies of olfactory dysfunction in major neurological disorders , 1995 .

[141]  C. Adler,et al.  MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI , 2011, Movement disorders : official journal of the Movement Disorder Society.

[142]  D. Burn,et al.  Parkinson's disease: The quintessential neuropsychiatric disorder , 2011, Movement disorders : official journal of the Movement Disorder Society.

[143]  Y. Ben-Shlomo,et al.  The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. , 2014, Parkinsonism & Related Disorders.

[144]  P. Rabbitt,et al.  Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. , 1994, Dementia.

[145]  J. Jankovic,et al.  Education Research: Patient telephone calls in a movement disorders center , 2009, Neurology.